Novel Drug Approvals for 2016
Drug Name:Novel Drug Approvals for 2016
List Of Brands:
Indication Type Description:
Indication
Indication:
Novel Drug Approvals for 2016
(For more salient details please refer the Drug)
No. Drug Name Active Ingred. Apprvl Date FDA Approved use on approved date
M- Manufacturer D- Distributor
1.Zepatier Elbasvir Jan 2016 To treat patients with chronic Hepatitis and Grazoprevir C virus (HCV) genotypes 1 and 4 inferctions in adult patients M by: MSD International GmbH, Ballydine, Clonmel, Ireland
2. Briviact Brivaracetam Feb 2016 To treat partial onset seizures in patients age 16 years and older with epilepsy
3.Anthim Obiltoaximabf Mar 2016 To treat inhalational antrax in combination with appropiate antibacterial drugs
4.Taltz Ixelizumab Mar 2016 To treat adults with moderate- to- severe plaque psoriasis
6.Defitelio Defibrotide Mar 2016 To treat adults and children who sodium develop hepatic veno-occlusive disease with additional kidney or lung abnormalities after they receive a stem cell transplant from blood or cell transplantation
D by: Jazz Pharmaceuticals, Inc. Palo Alto, CA 94304 DEFITELIO® is a registered trademark of Jazz Pharmaceuticals plc or its subsidiaries.
7. Venclexta Venetoclax Apr 2016 For chronic lymphocytic leukemia in patients with speecific chromosomal abnormality
M- Genetech Inc 8.Nuplazid Pimavanserin Apr 2016 To treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson's disease M-Acadia Pharmaceuticals Inc.
9.Tecentriq Atezolizumab May 2016 To treat urothelial carcinoma the most common type bladder cancer M-Genetech Inc
10. Zinbryta Daclizumab May 2016 To treat multiple sclerosis M-Biogen Inc
11. Oclavia Obeticholic acid May 2016 To treat rare, chronic liver disease M- Intercept Pharmaceuticals Inc
12.Axumin Fluciclovine F 118 May 2016 A new diagnostic imaging agent to detect recurrent postrate cancer M- Blue Earth Diagnostics Inc
13.NETSPOT Gallium Ga June 2016 A diagnostic imaging agent to detect 68 dotatate rare neuroendocrine tumors M- Gipharma SR Inc
14.Epclusa Sofosbuvir June 2016 To treat all six major forms of hepatitis and Velpatasvir C virus M- GI lead Sciences Inc.
15.Xildra Lifitegrast July 2016 To treat signs and symtoms of dry eye ophthalmic disease solution M- Shire US Inc.
16.Aldyxin Lixisenatide July 2016 To improve glycemic control (blood sugar Levels) M- Sanofi Aventis Inc.
17.Exondys 51 Eteplirsen Sep 2016 To treat patients with Dechenne muscular dystrophy M-Salepta Therapeutics Inc
18.Latruvo Olaratumab Oct 2016 To treat adults with certain types of soft tissue sarcoma M-Eli Lily Inc US
19.Zinplava Bezlotoxumab Oct 2016 To reduce the recurrence of Clostridium difficle infection in patients aged 18 years or older M-MSD Inc. US
20.Ercrisa Crisaborole Dec 2016 To treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older M- Avacor Inc.
21. Rubraca Rucaparib Dec 2016 To treat women with a certain tyoe of ovarian cancer M-Clouis Incology Inc. US
22.Spinraza Nusinersen Dec 2016 To treat children and adults with spinal muscular atrophy(SMA) M- Biogen Inc.